CJC-1295 Hormone support, energy & recovery What it helps with: improving growth hormone signaling, which can translate to better recovery, improved body composition, and increased energy in the right patients
In a head-to-head open-label trial reported in February 2026, average weight loss at 84 weeks favored tirzepatide, and the sponsor noted CagriSema did not meet its prespecified non-inferiority target against tirzepatide
Studies of other GLP-1 receptor agonists provide relevant context
doi: 10.3390/nu14030639
KEY INGREDIENTS: Purified Water, Glycerine, Shea Butter, Kojic Acid Dipalmitate, Isopropyl Myristate, Niacinamide, Olivem 1000, Coconut oil, Alpha Arbutin, Emulsifying Wax, Vitamin E, Glutathione, Sodium PCA, Magnesium Ascorbyl Phosphate, Sodium Benzoate, Potassium Sorbate, 2- Phenoxyethanol, Castor Oil, Titanium Dioxide, Lactic Acid, Immid Urea, Disodium EDTA, Zinc Oxide, Palmitoyl Tripeptide, Tripeptide, Butylated Hydroxytoluene, Solanum lycopersicum extract, Rubia cordifolia extract, Solanum tuberosum extract, Fragrance.
%25201.png)
